Entrada Therapeutics Inc

-0.75 (-4.65%)
4:02:28 PM EDT: $15.39 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)519.53M
Current PE22.12
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$51.86 Million
Adjusted EPS$0.36
See more estimates
10-Day MA$15.23
50-Day MA$13.69
200-Day MA$14.45
See more pivots

Entrada Therapeutics Inc Stock, NASDAQ:TRDA

One Design Center Place, Boston, Massachusetts 02210
United States of America
Phone: +1.857.520.9158
Number of Employees: 159


Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.